Back to Agenda
Digital Transformation in EU Regulatory Space
Session Chair(s)
Zaide Frias, PharmD
Head of Digital Business Transformation Task Force
European Medicines Agency, Netherlands
Rodrigo Palacios, MBA
Executive Director, Technical Regulatory Policy
F. Hoffmann-La Roche, Switzerland
Dive into the future of regulatory excellence with in this DIAmond session, on "Digital Transformation in the EU Regulatory Space." This session will focus on the concrete plans that have been made for digital transformation in the regulatory space for the next ten years and gathers Healthcare regulators, European Commission representatives, Patient advocates, Technology disruptors and Industry leaders to explore the critical success factors driving digital evolution. Join us and be part of the conversation that shapes the next era of regulatory dynamics. Don't miss your chance to navigate the transformative journey ahead.
See you at the forefront of regulatory innovation!
Speaker(s)
Digital Transformation in the New General Pharmaceutical Legislation
Lilia Luchianov, LLM, MBA
European Commission, Belgium
Policy Officer at DG Santé
NPAG, Network Developments, and Level Playing Field
Karl Broich, DrMed
Federal Institute for Drugs and Medical Devices (BfArM), Germany
President
International Collaboration
Lorraine Nolan, PhD
Health Products Regulatory Authority , Ireland
Chief Executive
NCA perspective on Digital Transformation & AI
Lars Bo Nielsen, MSc
Danish Medicines Agency (DKMA), Denmark
Director General
Medicine Innovation (Including RWE/RWD Future)
Álmath Spooner, PhD
Abbvie, Ireland
Head of Europe Regulatory Policy & Intelligence (RPI)
Andrew Warrington
Microsoft, Switzerland
Senior Industry Advisor in Health and Life Sciences
Patient Perspective
Jan Geissler, MBA
Patvocates, Germany
Managing Director
Have an account?